You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 18, May 13, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Quality of Care
 •Quality of Care, Other
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aspirin and Secondary Prevention in Peripheral Artery Disease

A Perspective for the Early 21st Century

Mary McGrae McDermott, MD; Michael H. Criqui, MD, MPH

JAMA. 2009;301(18):1927-1928.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Lower extremity peripheral artery disease (PAD) is common among older men and women in developed countries and will become increasingly prevalent as populations survive longer with chronic disease. Recent estimates in the United States indicate that 1 in 16 men and women 40 years or older have PAD.1 In primary care medical practices in the United States, nearly 30% of men and women who are either 70 years or older or aged 50 to 69 years with a history of diabetes or smoking have an ankle-brachial index (ABI) of less than 0.90, consistent with PAD.2

Multiple epidemiological studies completed during the past 20 years consistently demonstrate increased rates of cardiovascular morbidity and mortality among men and women with PAD compared with those without PAD even after adjusting for cardiovascular disease risk factors and history of cardiovascular events.3-4 Therefore, preventing cardiovascular events . . . [Full Text of this Article]

Author Affiliations: Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr McDermott); and Department of Family and Preventive Medicine, and Department of Medicine, University of California, San Diego School of Medicine, San Diego (Dr Criqui). Dr McDermott is a Contributing Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials
Jeffrey S. Berger, Mori J. Krantz, John M. Kittelson, and William R. Hiatt
JAMA. 2009;301(18):1909-1919.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Ankle-Brachial Index as a Biomarker of Cardiovascular Risk: It's Not Just About the Legs
Perlstein and Creager
Circulation 2009;120:2033-2035.
FULL TEXT  

Aspirin in Patients with Peripheral Artery Disease
JWatch General 2009;2009:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.